Table 2

Proportions of patients who achieved a CDAI-100 response and CDAI remission at week 8 and week 12

PF-00547659
Placebo22.5 mg75 mg225 mg
CDAI-100 response
Week 8
 N56505562
 Patients, %41.450.548.357.0
 90% CI–11.3 to 29.5–13.0 to 26.8–3.6 to 34.8
Week 12
 N54514961
 Patients, %44.456.047.753.8
 90% CI–8.7 to 31.9–17.3 to 24.0–10.1 to 29.1
CDAI remission
Week 8
 N57505662
 Patients, %16.729.123.826.9
 90% CI–5.2 to 29.9–9.2 to 23.4–6.2 to 26.6
Week 12
 N55514961
 Patients, %23.026.828.529.6
 90% CI–14.6 to 22.2–13.6 to 24.6–11.6 to 24.8
  • CDAI, Crohn’s Disease Activity Index.